The prognostic value of circulating markers of collagen turnover after acute myocardial infarction

International Journal of Cardiology

Volumn 150, Issue 3, 2011, Pages 277-282

  Manhenke, Cord ^a,b   Ørn, Stein ^a,b   Squire, Iain ^c   Radauceanu, Anca ^d   Alla, François ^e   Zannad, Faiez ^d   Dickstein, Kenneth ^a,b  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

^d Ctr Hospitalier Univ de Nancy   (France)

^e UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

Collagen turnover; Myocardial infarction; Prognosis; Remodelling

Indexed keywords

ACETYLSALICYLIC ACID; AMINO TERMINAL TELOPEPTIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; CARBOXY TERMINAL TELOPEPTIDE; COLLAGEN; COLLAGEN TYPE 3; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERSTITIAL COLLAGENASE; LOSARTAN; WARFARIN;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYMPTOMATOLOGY; SYSTOLIC BLOOD PRESSURE;

AGED; BIOLOGICAL MARKERS; COHORT STUDIES; COLLAGEN TYPE I; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 79960558372     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2010.04.034     Document Type: Article

References (31)

1. B.I. Jugdutt Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough? Circulation 108 2003 1395 1403 (Pubitemid 37174420)
2. B.I. Jugdutt, M.J. Joljart, and M.I. Khan Rate of Collagen Deposition During Healing and Ventricular Remodeling After Myocardial Infarction in Rat and Dog Models Circulation 94 1996 94 101 (Pubitemid 126426405)
3. J.P. Cleutjens, M.J. Verluyten, J.F. Smiths, and M.J. Daemen Collagen remodeling after myocardial infarction in the rat heart Am J Pathol 147 1995 325 338
4. P. Uusimaa, J. Risteli, and M. Niemela Collagen scar formation after acute myocardial infarction: relationships to infarct size, left ventricular function, and coronary artery patency Circulation 96 1997 2565 2572 (Pubitemid 27451347)
5. J. Risteli, I. Elomaa, S. Niemi, A. Novamo, and L. Risteli Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone collagen degradation Clin Chem 39 1993 635 640 (Pubitemid 23118314)
6. A.H. Bruggink, M.F. van Oosterhout, and N. de Jonge Reverse remodeling of the myocardial extracellular matrix after prolonged left ventricular assist device support follows a biphasic pattern J Heart Lung Transplant 25 2006 1091 1098 (Pubitemid 44311529)
7. B. Schwartzkopff, M. Fassbach, B. Pelzer, M. Brehm, and B.E. Strauer Elevated serum markers of collagen degradation in patients with mild to moderate dilated cardiomyopathy Eur J Heart Fail 4 2002 439 444 (Pubitemid 36564961)
8. T. Murakami, S. Kusachi, and M. Murakami Time-dependent changes of serum carboxy-terminal peptide of type I procollagen and carboxy-terminal telopeptide of type I collagen concentrations in patients with acute myocardial infarction after successful reperfusion: correlation with left ventricular volume indices Clin Chem 44 1998 2453 2461 (Pubitemid 28565657)
9. W. Iraqi, P. Rossignol, and M. Angioi Extracellular Cardiac Matrix Biomarkers in Patients With Acute Myocardial Infarction Complicated by Left Ventricular Dysfunction and Heart Failure: Insights From the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) Study Circulation 119 2009 2471 2479
10. G. Cerisano, G. Parodi, and E.V. Dovellini Time course of serum collagen types I and III metabolism products after reperfused acute myocardial infarction in patients with and without systemic hypertension J Hum Hypertens 23 2009 40 47
11. F. Zannad, B. Dousset, and F. Alla Treatment of congestive heart failure: interfering the aldosterone-cardiac extracellular matrix relationship Hypertension 38 2001 1227 1232 (Pubitemid 34252836)
12. J. Diez, R. Querejeta, B. Lopez, A. Gonzalez, M. Larman, and J.L. Martinez Ubago Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients Circulation 105 2002 2512 2517 (Pubitemid 34568973)
13. D. Kelly, S.Q. Khan, and M. Thompson Plasma tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9: novel indicators of left ventricular remodelling and prognosis after acute myocardial infarction Eur Heart J 29 2008 2116 2124
14. K. Dickstein, and J. Kjekshus Comparison of the effects of losartan and captopril on mortality in patients after acute myocardial infarction: the OPTIMAAL trial design. Optimal Therapy in Myocardial Infarction with the Angiotensin II Antagonist Losartan Am J Cardiol 83 1999 477 481 (Pubitemid 29097941)
15. K. Dickstein, and J. Kjekshus Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan Lancet 360 2002 752 760 (Pubitemid 35247704)
16. J. Risteli, S. Niemi, P. Trivedi, O. Maentausta, A.P. Mowat, and L. Risteli Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type III procollagen Clin Chem 34 1988 715 718
17. J. Melkko, S. Kauppila, and S. Niemi Immunoassay for intact amino-terminal propeptide of human type I procollagen Clin Chem 42 1996 947 954
18. M. Lein, L. Nowak, and K. Jung Analytical aspects regarding the measurement of metalloproteinases and their inhibitors in blood Clin Biochem 30 1997 491 496 (Pubitemid 27418546)
19. T. Omland, A. Persson, and L. Ng N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes Circulation 106 2002 2913 2918 (Pubitemid 35424741)
20. S.H. Poulsen, N.B. Host, S.E. Jensen, and K. Egstrup Relationship between serum amino-terminal propeptide of type III procollagen and changes of left ventricular function after acute myocardial infarction Circulation 101 2000 1527 1532 (Pubitemid 30180888)
21. J. Diez, and C. Laviades Monitoring fibrillar collagen turnover in hypertensive heart disease Cardiovasc Res 35 1997 202 205 (Pubitemid 27372031)
22. J.F. Woessner Jr. Matrix metalloproteinases and their inhibitors in connective tissue remodeling Faseb J 5 1991 2145 2154 (Pubitemid 21905847)
23. Y. Inokubo, H. Hanada, H. Ishizaka, T. Fukushi, T. Kamada, and K. Okumura Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome Am Heart J 141 2001 211 217 (Pubitemid 32128725)
24. C.S. Webb, D.D. Bonnema, and S.H. Ahmed Specific temporal profile of matrix metalloproteinase release occurs in patients after myocardial infarction: relation to left ventricular remodeling Circulation 114 2006 1020 1027 (Pubitemid 44358878)
25. E. Cavusoglu, C. Ruwende, and V. Chopra Tissue inhibitor of metalloproteinase-1 (TIMP-1) is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction Am Heart J 151 2006 e1 e8
26. M.J. West, P.J. Nestel, and A.C. Kirby The value of N-terminal fragment of brain natriuretic peptide and tissue inhibitor of metalloproteinase-1 levels as predictors of cardiovascular outcome in the LIPID study Eur Heart J 29 2008 923 931 (Pubitemid 351499477)
27. E. Lubos, R. Schnabel, and H.J. Rupprecht Prognostic value of tissue inhibitor of metalloproteinase-1 for cardiovascular death among patients with cardiovascular disease: results from the AtheroGene study Eur Heart J 27 2006 150 156 (Pubitemid 43069030)
28. I.B. Squire, S. Orn, and L.L. Ng Plasma natriuretic peptides up to 2 years after acute myocardial infarction and relation to prognosis: an OPTIMAAL substudy J Cardiac Fail 11 2005 492 497 (Pubitemid 41399888)
29. S. Orn, C. Manhenke, and O.J. Greve Microvascular obstruction is a major determinant of infarct healing and subsequent left ventricular remodelling following primary percutaneous coronary intervention Eur Heart J 30 2009 1978 1985
30. I.B. Squire, J. Evans, L.L. Ng, I.M. Loftus, and M.M. Thompson Plasma MMP-9 and MMP-2 following acute myocardial infarction in man: correlation with echocardiographic and neurohumoral parameters of left ventricular dysfunction J Cardiac Fail 10 2004 328 333 (Pubitemid 39092685)
31. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150